Health Catalyst, Inc. — Director's Dealing 2019

Jul 25, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2019-07-24

Reporting Person: Orenstein Daniel H. (General Counsel)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$10.34	2026-02-10	Common Stock (175000.0)		Direct
Stock Option (Right to Buy)	$10.8	2028-09-27	Common Stock (25000.0)		Direct

Footnotes

F1: 25% of the shares vested on December 31, 2016; and the remaining 75% vest in 36 equal monthly installments thereafter.

F2: 25% of the shares shall vest on September 25, 2019; and the remaining 75% vest in 36 equal monthly installments thereafter.